Isao Matsumoto Selected Research

Antirheumatic Agents (DMARD)

6/2019	Effect of Biological Disease-modifying Anti-rheumatic Drugs on Airway and Interstitial Lung Disease in Patients with Rheumatoid Arthritis.
1/2016	Evaluation of changes in magnetic resonance images following 24 and 52 weeks of treatment of rheumatoid arthritis with infliximab, tocilizumab, or abatacept.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Isao Matsumoto Research Topics

Disease

56	Rheumatoid Arthritis 01/2024 - 08/2002
40	Arthritis (Polyarthritis) 01/2024 - 04/2002
26	Neoplasms (Cancer) 04/2024 - 01/2003
21	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2024 - 04/2004
11	Immunoglobulin G4-Related Disease 01/2024 - 07/2012
10	Sialadenitis 05/2024 - 07/2010
10	Lung Neoplasms (Lung Cancer) 02/2024 - 05/2004
10	Autoimmune Diseases (Autoimmune Disease) 03/2021 - 04/2002
8	Experimental Arthritis 01/2024 - 06/2006
7	Neoplasm Metastasis (Metastasis) 02/2024 - 08/2004
7	Inflammation (Inflammations) 01/2021 - 01/2009
6	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023 - 08/2004
6	Fibrosis (Cirrhosis) 01/2021 - 07/2012
6	Lymphatic Metastasis 03/2017 - 08/2004
5	Carcinoma (Carcinomatosis) 09/2023 - 05/2003
5	Osteoarthritis 10/2018 - 06/2004
5	Necrosis 04/2009 - 03/2003
4	Dermatomyositis (Dermatopolymyositis) 01/2022 - 01/2006
4	Connective Tissue Diseases (Connective Tissue Disease) 05/2021 - 03/2013
4	Interstitial Lung Diseases (Interstitial Lung Disease) 06/2019 - 01/2006
3	Hemorrhage 12/2022 - 04/2009
3	Myositis (Idiopathic Inflammatory Myopathies) 04/2022 - 07/2020
3	Malignant Mesothelioma 10/2020 - 01/2014
3	Synovitis 12/2012 - 09/2005
2	Exanthema (Rash) 12/2022 - 01/2022
2	Adult-Onset Still's Disease 12/2022 - 04/2018
2	Chronic Obstructive Pulmonary Disease (COPD) 11/2022 - 09/2022
2	Amyopathic dermatomyositis 01/2021 - 07/2018
2	Pleurisy (Pleuritis) 10/2020 - 04/2018
2	Aortitis 10/2020 - 01/2009
2	Polymyositis 07/2020 - 01/2006

Drug/Important Bio-Agent (IBA)

23	Proteins (Proteins, Gene)FDA Link 01/2024 - 01/2009
22	AntibodiesIBA 05/2024 - 04/2002
20	Peptides (Polypeptides)IBA 07/2021 - 01/2006
16	Glucose-6-Phosphate Isomerase (Phosphoglucose Isomerase)IBA 03/2020 - 04/2002
15	AutoantibodiesIBA 05/2024 - 08/2002
14	Interleukin-6 (Interleukin 6)IBA 12/2022 - 01/2008
14	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2014 - 06/2004
12	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021 - 01/2007
12	LigandsIBA 09/2020 - 01/2006
11	Interleukin-17 (Interleukin 17)IBA 09/2020 - 01/2008
10	CytokinesIBA 12/2022 - 01/2008
9	Immunoglobulin G (IgG)IBA 01/2024 - 09/2005
9	EnzymesIBA 08/2015 - 04/2002
7	DNA (Deoxyribonucleic Acid)IBA 04/2024 - 06/2007
7	Prednisolone (Predate)FDA LinkGeneric 01/2024 - 01/2004
7	Infliximab (Remicade)FDA Link 11/2023 - 07/2007
7	Cyclosporine (Ciclosporin)FDA LinkGeneric 07/2023 - 01/2007
7	Immunoglobulins (Immunoglobulin)IBA 04/2021 - 04/2002
7	Muscarinic Receptors (Muscarinic Acetylcholine Receptor)IBA 09/2020 - 12/2010
7	IsomerasesIBA 04/2012 - 08/2002
6	Abatacept (Orencia)FDA Link 01/2023 - 11/2014
6	Messenger RNA (mRNA)IBA 01/2020 - 06/2004
6	tocilizumab (atlizumab)FDA Link 04/2018 - 01/2007
6	AntigensIBA 06/2014 - 06/2006
5	Monoclonal AntibodiesIBA 01/2024 - 01/2008
5	Cyclophosphamide (Cytoxan)FDA LinkGeneric 07/2023 - 01/2012
5	SteroidsIBA 07/2018 - 01/2004
5	Collagen Type II (Type II Collagen)IBA 10/2014 - 01/2006
4	Tyrosine Kinase InhibitorsIBA 02/2024 - 11/2009
4	Therapeutic UsesIBA 01/2023 - 01/2008
4	HLA-DRB1 Chains (HLA DRB1)IBA 01/2023 - 01/2006
4	beta-cyclodextrin tetradecasulfate (CTDS)IBA 05/2021 - 03/2013
4	Anti-Citrullinated Protein AntibodiesIBA 03/2020 - 08/2015
4	InterleukinsIBA 12/2016 - 01/2008
4	Methotrexate (Mexate)FDA LinkGeneric 07/2015 - 01/2009
4	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2013 - 08/2004
4	Vascular Endothelial Growth Factor CIBA 08/2013 - 08/2004
4	TristetraprolinIBA 01/2008 - 06/2004
3	Biomarkers (Surrogate Marker)IBA 04/2024 - 01/2014
3	osimertinibIBA 02/2024 - 01/2019
3	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2024 - 12/2017
3	Transcription Factors (Transcription Factor)IBA 01/2021 - 01/2018
3	AutoantigensIBA 03/2020 - 10/2004
3	acetyl 4-aminosalicylic acidIBA 01/2017 - 08/2015
3	T-Cell Antigen Receptors (T-Cell Receptor)IBA 05/2015 - 01/2006
3	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 05/2015 - 01/2008
3	Immunosuppressive Agents (Immunosuppressants)IBA 01/2012 - 01/2007
3	thiamine triphosphorate (TTP)IBA 01/2008 - 06/2004
3	Morphine (MS Contin)FDA LinkGeneric 03/2007 - 03/2003
3	Complementary DNA (cDNA)IBA 08/2006 - 06/2004
3	Codeine (Codeine Phosphate)FDA LinkGeneric 05/2003 - 03/2003
2	ErbB Receptors (EGF Receptor)IBA 02/2024 - 11/2009
2	GlucocorticoidsIBA 01/2024 - 07/2023
2	inter-alpha-inhibitorIBA 01/2024 - 10/2018
2	Mycophenolic Acid (Cellcept)FDA LinkGeneric 07/2023 - 03/2021
2	Bronchodilator Agents (Bronchodilators)IBA 11/2022 - 09/2022
2	nuclear matrix protein 2IBA 01/2022 - 01/2021
2	Interferon-gamma (Interferon, gamma)IBA 01/2022 - 03/2008
2	HLA Antigens (Human Leukocyte Antigens)IBA 07/2020 - 01/2014
2	CC ChemokinesIBA 07/2020 - 01/2020

Therapy/Procedure

21	Therapeutics 02/2024 - 08/2002
5	Oral Administration 09/2020 - 01/2014
5	Drug Therapy (Chemotherapy) 06/2020 - 01/2003
3	Radiotherapy 01/2020 - 05/2012
2	Adjuvant Chemotherapy 04/2024 - 02/2006
2	Segmental Mastectomy (Lumpectomy) 11/2023 - 04/2005
2	Chemoradiotherapy 09/2023 - 05/2012
2	Thoracotomy 12/2022 - 02/2013
2	Plasma Exchange 12/2020 - 07/2018